Raymond Rodriguez-Torres Named President of First Ascent Biomedical

Rodriguez-Torres steps into the role at a critical juncture for the Miami-based company. First Ascent Biomedical is currently pushing to move cancer treatment away from population-based assumptions toward biology-driven, patient-specific support. His mandate includes expanding strategic partnerships and accelerating the adoption of the company's xDRIVE platform, which integrates live-cell drug sensitivity testing with AI to guide clinical decisions.

Beyond his corporate background, Rodriguez-Torres serves as chairman of the Live Like Bella Childhood Cancer Foundation. Founded following the death of his daughter, the organization has supported families in over 30 countries. This personal history informs his approach to the company's core technology, which has already been validated in a study published in Nature Medicine. The platform provides actionable reports for physicians in an average of 10 days, covering 52 cancer types. CEO Jim Foote noted that Rodriguez-Torres was chosen for his rare blend of operational discipline and the conviction required to navigate the high-stakes reality of refractory cancer treatment.